Patents Assigned to Ipsen Pharma S.A.S.
  • Ghrelin analogs
    Patent number: 7589058
    Abstract: The invention comprises peptidyl analogs that possess agonist or antagonist ghrelin activity, along with therapeutic and non-therapeutic uses thereof.
    Type: Grant
    Filed: July 23, 2003
    Date of Patent: September 15, 2009
    Assignee: Ipsen Pharma, S.A.S.
    Inventors: Zheng Xin Dong, Yeelena Shen
  • Derivatives of amidines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
    Patent number: 7576241
    Abstract: A compound of the formula wherein the substituents are defined as in the specification useful as intermediates.
    Type: Grant
    Filed: October 14, 2005
    Date of Patent: August 18, 2009
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Serge Auvin, Pierre-Etienne Chabrier de Lassauniere, Jeremiah Harnett, Dominique Pons, Gerard Ulibarri
  • Farnesyl transferase inhibitors
    Patent number: 7553975
    Abstract: A family of compounds capable of inhibiting the activity of farnesyl transferase.
    Type: Grant
    Filed: May 30, 2006
    Date of Patent: June 30, 2009
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Thomas D. Gordon, Barry A. Morgan
  • Somatostatin-dopamine chimeric analogs
    Patent number: 7517853
    Abstract: The invention features somatostatin-dopamine chimeric analogs and methods relating to their therapeutic use for the treatment of neoplasia, acromegaly, and other conditions.
    Type: Grant
    Filed: April 8, 2004
    Date of Patent: April 14, 2009
    Assignee: Ipsen Pharma S.A.S.
    Inventors: Zheng Xin Dong, Michael DeWitt Culler, Yeelena Shen